Investigador en Ciencias Médicas Hospital Infantil de México Federico Gómez Mexcio
María del Carmen Maldonado Bernal is a distinguished medical scientist born on April 10, 1956, in Mexico City. Currently, she is an esteemed researcher at the Hospital Infantil de México Federico Gómez, specializing in immunology and proteomics. With a prolific career in medical research, María’s work primarily focuses on the immune response in pediatric cancers and infectious diseases.
Profile
Scopus
Education 🎓
María del Carmen holds a Doctorate in Sciences with a specialization in Immunology from the Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (2003), where her research earned an honorary mention. She also completed a Master’s in Experimental Biology from the Universidad Autónoma Metropolitana (1998) and a Bachelor’s degree as a Chemical Bacteriologist and Parasitologist from the Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (1982).
Experience 💼
María del Carmen has an extensive professional background, having held significant research positions at the Hospital Infantil de México Federico Gómez, Instituto Mexicano del Seguro Social, and various other institutions. Her research includes studying immune mechanisms in pediatric cancer and inflammatory responses in cancer related to bacterial and viral infections. She has also served as a coordinator and head of various departments in quality control and immunochemistry.
Research Interests 🔬
Her research interests are primarily focused on:
- Activation and modulation mechanisms of the antineoplastic immune response in pediatric cancer.
- Inflammatory responses in cancers associated with bacterial and viral infections.
- Immune responses in infectious diseases.
Awards 🏆
María del Carmen has received numerous awards, including recognition for her exceptional research in immunology and contributions to pediatric cancer studies. She is also a Level II member of the Sistema Nacional de Investigadores, reflecting her significant contributions to scientific research in Mexico.
Publications 📚
- Gallardo-Zapata, J., et al. (2024). TLR Agonists Modify NK Cell Activation and Increase Its Cytotoxicity in Acute Lymphoblastic Leukemia. Int J Mol Sci, 25, 7500. Read Article
- Juarez Lopez, A.L., Maldonado Bernal, C., Sánchez Zauco, N.A. (2023). Is the epithelial-mesenchymal transition an ally or an enemy of cancer? J Gastroenterol Res Pract, 3(10), 1174. Read Article
- Flores-Alanis, A., et al. (2022). Clinical Characteristics of Coronavirus Disease (COVID-19) in Mexican Children and Adolescents. Viruses, 14(10), 2162. doi: 10.3390/v14102162. Read Article
- Alteri, C.J., et al. (2022). The Flp type IV pilus operon of Mycobacterium tuberculosis is expressed upon interaction with macrophages and alveolar epithelial cells. Front Cell Infect Microbiol, 12, 916247. doi: 10.3389/fcimb.2022.916247. Read Article
- González-Garza, M.T., et al. (2022). Interleukin-10 as the best biomarker to potential therapy targets in pediatric patients with acute lymphoblastic leukemia. Trends in Cancer Research, 17, 45-55. Read Article